Estimates Revisions Spero Therapeutics, Inc. Börse Stuttgart

Stocks

Real-time Estimate Tradegate Other stock markets 15:22:22 23/07/2026 BST			5-day change	1st Jan Change
1.078 ^EUR	-2.09%		-24.28%	-42.24%

07-15	Innovent Biologics Shares Surge on Spero Deal That Could Be Worth $1.1 Billion	DJ
07-14	Innovent Biologics, Inc. and Spero Therapeutics, Inc. Announce Exclusive License Agreement for IBI355, Phase 2-Ready Third-Generation Anti-CD40L Antibody	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	WUXI APPTEC CO., LTD.
	ARGENX SE
	INSMED INCORPORATED
	BIONTECH SE
	WUXI BIOLOGICS (CAYMAN) INC.
	GENMAB A/S
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
	PHARMAESSENTIA CORPORATION
	EXELIXIS, INC.
	Average
	Weighted average by Cap.